BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1910 related articles for article (PubMed ID: 19430340)

  • 1. Postmenopausal hormone therapy and the risk of cardiovascular disease.
    Stramba-Badiale M
    J Cardiovasc Med (Hagerstown); 2009 Apr; 10(4):303-9. PubMed ID: 19430340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Climacteric medicine: European Menopause and Andropause Society (EMAS) 2004/2005 position statements on peri- and postmenopausal hormone replacement therapy.
    Skouby SO; Al-Azzawi F; Barlow D; Calaf-Alsina Erdogan Ertüngealp J; Gompel A; Graziottin A; Hudita D; Pines A; Rozenberg S; Samsioe G; Stevenson JC;
    Maturitas; 2005 May; 51(1):8-14. PubMed ID: 15883103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Why a consensus conference on hormone replacement therapy and the cardiovascular system?
    Benagiano G; Farris M
    Maturitas; 2004 Apr; 47(4):245-53. PubMed ID: 15063475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hormone replacement therapy and cardioprotection: what is good and what is bad for the cardiovascular system?
    Rosano GM; Vitale C; Fini M
    Ann N Y Acad Sci; 2006 Dec; 1092():341-8. PubMed ID: 17308159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Historical perspective of hormone replacement therapy].
    Chanson P
    Rev Prat; 2005 Feb; 55(4):369-75. PubMed ID: 15828614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hormone replacement therapy and cardioprotection: a new dawn? A statement of the Study Group on Cardiovascular Disease in Women of the Italian Society of Cardiology on hormone replacement therapy in postmenopausal women.
    Rosano GM; Maffei S; Andreassi MG; Vitale C; Vassalle C; Gambacciani M; Stramba-Badiale M; Mercuro G
    J Cardiovasc Med (Hagerstown); 2009 Jan; 10(1):85-92. PubMed ID: 19145119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hormone replacement therapy in postmenopausal women.
    Yasui T; Uemura H; Takikawa M; Irahara M
    J Med Invest; 2003 Aug; 50(3-4):136-45. PubMed ID: 13678382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Benefits of hormone replacement therapy--overview and update.
    Calaf i Alsina J
    Int J Fertil Womens Med; 1997; 42 Suppl 2():329-46. PubMed ID: 9397382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hormone replacement therapy use and menopausal symptoms among women participating in a behavioral lifestyle intervention.
    Boraz MA; Simkin-Silverman LR; Wing RR; Meilahn EN; Kuller LH
    Prev Med; 2001 Aug; 33(2 Pt 1):108-14. PubMed ID: 11493043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medical issues and hormone replacement therapy.
    Harris PF
    Curr Womens Health Rep; 2002 Oct; 2(5):373-81. PubMed ID: 12215310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HRT and the primary prevention of cardiovascular disease.
    Stevenson JC
    Maturitas; 2007 May; 57(1):31-4. PubMed ID: 17383835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sex hormone replacement therapy and modulation of vascular function in cardiovascular disease.
    Koledova VV; Khalil RA
    Expert Rev Cardiovasc Ther; 2007 Jul; 5(4):777-89. PubMed ID: 17605655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Postmenopausal hormone-replacement therapy discredited, except in healthy women shortly after menopause].
    Maas AH; van der Graaf Y
    Ned Tijdschr Geneeskd; 2002 Nov; 146(45):2127-30. PubMed ID: 12474550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of hormone replacement therapy on metabolic syndrome components in perimenopausal women.
    Korljan B; Bagatin J; Kokić S; Berović Matulić N; Barsić Ostojić S; Deković A
    Med Hypotheses; 2010 Jan; 74(1):162-3. PubMed ID: 19665311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Controversies over hormone replacement therapy. HRT as a risk factor of breast cancer in postmenopausal women.
    Licznerska BE; Baer-Dubowska W
    Acta Pol Pharm; 2005; 62(3):241-7. PubMed ID: 16193819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postmenopausal hormone replacement therapy and cardiovascular disease.
    Chae CU; Ridker PM; Manson JE
    Thromb Haemost; 1997 Jul; 78(1):770-80. PubMed ID: 9198254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hormone replacement therapy in postmenopausal women.
    Prelevic GM; Kocjan T; Markou A
    Minerva Endocrinol; 2005 Mar; 30(1):27-36. PubMed ID: 15877011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hormone replacement therapy in women with a history of breast cancer.
    Ylikorkala O; Metsä-Heikkilä M
    Gynecol Endocrinol; 2002 Dec; 16(6):469-78. PubMed ID: 12626034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigative models for determining hormone therapy-induced outcomes in brain: evidence in support of a healthy cell bias of estrogen action.
    Brinton RD
    Ann N Y Acad Sci; 2005 Jun; 1052():57-74. PubMed ID: 16024751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic features of menopausal and postmenopausal applicants for life insurance.
    Schiefeling M
    J Insur Med; 1996; 28(1):27-34. PubMed ID: 10172866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 96.